Behavior and sleep disturbance in Smith-Magenis syndrome.


Journal

Current opinion in psychiatry
ISSN: 1473-6578
Titre abrégé: Curr Opin Psychiatry
Pays: United States
ID NLM: 8809880

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 18 12 2018
medline: 7 3 2020
entrez: 18 12 2018
Statut: ppublish

Résumé

To provide an update of the most recent studies on Smith-Magenis syndrome (SMS) with a focus on the unique pattern of behavioral and sleep disturbances associated with the condition. The recent literature on SMS has focused on the characteristic severe behavioral and sleep disturbances. A better understanding of the underlying pathophysiological mechanisms and common clinical course has helped further characterize SMS, while much is left to be discovered in regard to effective treatment/management. SMS is a difficult to manage genetic condition defined by pervasive and progressive behavioral and sleep disturbances with a unique pattern that can often be easily discerned from other neurodevelopmental disorders. Common behavioral features include maladaptive/self-injurious, aggressive, stereotypic, and the newly appreciated food seeking behaviors associated with SMS. In addition, there is a sleep disturbance defined by an altered circadian rhythm with frequent nighttime waking and daytime sleepiness, causing patients and families significant distress. Small studies have suggested some treatment/management approaches to the behavioral and sleep disturbances, however, much remains to be discovered.

Identifiants

pubmed: 30557269
doi: 10.1097/YCO.0000000000000474
pmc: PMC6362978
mid: NIHMS1518768
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-78

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM007526
Pays : United States

Références

Appl Clin Genet. 2017 Nov 03;10:85-94
pubmed: 29138588
Am J Ment Retard. 2001 Jan;106(1):52-8
pubmed: 11246713
J Autism Dev Disord. 2016 Jun;46(6):2148-2159
pubmed: 26983920
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):362-369
pubmed: 29346496
J Assoc Genet Technol. 2005;31(4):163-7
pubmed: 16354942
J Autism Dev Disord. 2017 Aug;47(8):2602-2609
pubmed: 28500573
Am J Hum Genet. 1997 May;60(5):1184-93
pubmed: 9150166
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10744-10749
pubmed: 30275311
CNS Neurosci Ther. 2016 Nov;22(11):928-935
pubmed: 27743421
Am J Med Genet A. 2011 Aug;155A(8):2024-7
pubmed: 21739587
Neuron. 2016 Oct 19;92(2):392-406
pubmed: 27693255
Pediatr Neurol. 2009 Oct;41(4):250-8
pubmed: 19748044
Diabetes. 2006 Dec;55(12):3366-71
pubmed: 17130481
Tijdschr Psychiatr. 2010;52(10):719-23
pubmed: 20931486
Am J Hum Genet. 2012 Jun 8;90(6):941-9
pubmed: 22578325
J Intellect Disabil Res. 1998 Oct;42 ( Pt 5):331-40
pubmed: 9828063
J Pediatr. 2006 Sep;149(3):409-11
pubmed: 16939758
Pediatr Neurol. 2006 May;34(5):337-50
pubmed: 16647992
J Med Genet. 2001 Sep;38(9):586-90
pubmed: 11546826
J Intellect Disabil Res. 2011 Feb;55(2):138-51
pubmed: 21199049
Clin Genet. 2007 Jun;71(6):540-50
pubmed: 17539903
Mol Cell Endocrinol. 2006 Jun 27;252(1-2):88-91
pubmed: 16723183
J Clin Endocrinol Metab. 2012 Feb;97(2):E312-8
pubmed: 22162479
BMJ Case Rep. 2016 Aug 05;2016:
pubmed: 27495174
Am J Med Genet C Semin Med Genet. 2010 Nov 15;154C(4):463-8
pubmed: 20981776
J Neurodev Disord. 2018 Jan 10;10(1):2
pubmed: 29329513
Orphanet J Rare Dis. 2015 Sep 04;10:111
pubmed: 26336863
Res Dev Disabil. 2015 Dec;47:27-38
pubmed: 26323055
Curr Opin Neurol. 2007 Apr;20(2):125-34
pubmed: 17351481
Res Dev Disabil. 2013 Dec;34(12):4355-65
pubmed: 24120292
Neurosci Biobehav Rev. 2018 Jan;84:483-491
pubmed: 28694012
J Speech Lang Hear Res. 2017 Apr 14;60(4):1076-1087
pubmed: 28384694
Hum Mol Genet. 2010 Oct 15;19(20):4026-42
pubmed: 20663924
Genet Med. 2006 Jul;8(7):417-27
pubmed: 16845274
Phys Occup Ther Pediatr. 2012 Feb;32(1):48-65
pubmed: 21599572
J Pediatr Genet. 2017 Sep;6(3):155-164
pubmed: 28794907
J Neurodev Disord. 2018 Mar 1;10(1):9
pubmed: 29490614
Am J Med Genet A. 2017 Jan;173(1):231-238
pubmed: 27683195
Am J Med Genet. 1998 Apr 28;77(1):23-7
pubmed: 9557889

Auteurs

Brian J Shayota (BJ)

Department of Molecular and Human Genetics, Baylor College of Medicine.
Texas Children's Hospital, Houston, Texas, USA.

Sarah H Elsea (SH)

Department of Molecular and Human Genetics, Baylor College of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH